Fred Aslan

Chief Executive Officer, Director, Artiva Biotherapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$1.8M

Companies

Latest trade

Oct 6, 2026

Companies

Artiva Biotherapeutics, Inc.Chief Executive Officer, Director −$2.0M

Trades

ARTV Sold 23,463 shares at $7.20 · planned $0.2M Oct 6

ARTV Sold 61,696 shares at $6.84 $0.4M Oct 5

ARTV Sold 23,429 shares at $10.92 · planned $0.3M Sep 8

ARTV Sold 61,888 shares at $11.16 $0.7M Sep 3

ARTV Sold 27,116 shares at $9.01 $0.2M May 19

ARTV Sold 3,187 shares at $6.00 · planned $0.0M Dec 15

ARTV Sold 6,375 shares at $3.38 · planned $0.0M Nov 17

ARTV Sold 25,500 shares at $6.00 · planned $0.2M Oct 17

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.